**Core tip:** The complex mechanisms of warm Ischemia reperfusion (I/R) injury in the liver are diverse and have been widely studied but poorly understood. This study aims to investigate the ultrastructural changes at warm I/R injury induced by portal triad clamping. The effects were mainly borne by the liver sinusoidal endothelial cells (LSEC) which detached from the sinusoidal wall after ischemia. Interestingly we found that the LSECs reattached after reperfusion. Hepatocytes were unaffected except for the appearance of crystalline inclusions in the mitochondria. Investigation of redox related proteins showed no changes within our time frame.

INTRODUCTION
============

Ischemia-reperfusion (I/R) injury is a known cause of tissue damage during liver resection and transplantation with direct impact on patients' postoperative morbidity and mortality\[[@B1],[@B2]\]. It is a biphasic phenomenon whereby the initial hypoxic damage is compounded upon restoration of blood supply along with oxygen delivery. The mechanisms of injury are complex and have been widely studied but remain poorly understood. Hepatic I/R injury is classified as warm or cold, where warm ischemia occurs when the blood supply to the liver is interrupted during liver resection, transplantation, trauma, and shock. Cold storage ischemia occurs during organ preservation in cold preservation solutions before transplantation\[[@B3]\]. Although both mechanisms share similarities, there are fundamental differences between warm and cold hepatic I/R injury. Existing knowledge indicates that warm I/R injury inflicts hepatocyte damage, while cold I/R injury is primarily characterized by injury to the sinusoidal endothelial lining\[[@B4]\].

Blood loss is one of the significant determinants of morbidity and tumor recurrence after hepatectomy\[[@B5]\]. Portal triad clamping (PTC), also known as the Pringle maneuver, has been one of the most widely used methods to reduce blood loss during hepatic surgery and involves clamping of the hepatic vascular inflow. PTC causes warm I/R injury in the remnant liver, the consequences of which are determined by the duration of clamping and the underlying health status of the liver parenchyma.

While there is vast literature regarding the biochemical and metabolic alterations associated with hepatic I/R injury, studies investigating the cellular and ultrastructural changes occurring in the liver as a result of I/R injury have mainly involved animal models and data from human studies are limited\[[@B6]-[@B10]\].

The ischemic injury occurs as a result of a reduction in blood supply and switching from aerobic to anaerobic metabolism. The initial ischemic insult followed by the sudden oxygen burst upon the reestablishment of vascular flow causes reperfusion injury which to a large extent is ascribed to the production of reactive oxygen species (ROS) and associated cellular injury\[[@B11]-[@B13]\]. There are several proteins involved in ROS scavenging and antioxidant defense. Many are regulated at transcriptional level through binding of nuclear factor (erythroid-derived 2)-like 2 (NRF2)\[[@B14]\], to the Antioxidant-Response Element (ARE) localized upstream of the promotor of these genes. By the same mechanism, *Nrf2* regulates glutamate-cysteine ligase (GCLC) and cysteine/glutamate antiporter (xCT), which are essential for glutathione (GSH) synthesis. GSH maintains the cellular redox balance and is considered as one of the most important cellular antioxidants\[[@B15],[@B16]\]. Thioredoxin (TRX) and glutaredoxin (GRX) are two intricate reduction systems belonging to the thioredoxin superfamily of proteins and are ubiquitously expressed in all cell types\[[@B17]-[@B19]\]. There is a lack of information on the involvement of these redox systems in hepatic I/R injury.

The present study aimed at investigating the effects of warm I/R injury induced by PTC in the human liver at the ultrastructural level, determining the degree and character of hepatocyte damage, and the sinusoidal endothelial lining. In addition, the impact of I/R injury on redox proteins was studied, in particular the TRX and GRX systems.

MATERIALS AND METHODS
=====================

Patients
--------

Eleven patients (8 men and 3 women), undergoing liver resection for differing indications, but without preoperative clinical or biochemical signs of chronic liver disease, were included in the study. Seven of the patients had colorectal liver metastases and all of them had received preoperative chemotherapy. Two patients had melanoma metastases to the liver and one had metastases from a bowel carcinoid. One patient was operated because of a suspected hepatocellular carcinoma, which on final histopathology turned out to be an inflammatory pseudotumor. The study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki and was approved by the Regional Ethics Committee for human studies, Stockholm, Sweden. All patients were informed orally and in writing and gave written consent.

Study protocol and biopsy acquisition
-------------------------------------

Laparotomy was performed by a right subcostal incision with an upper midline extension and the falciform ligament then divided. The hepatoduodenal ligament was isolated and a PTC then performed by placing a soft cloth tape around the porta hepatis over which a rubber tubing was then slid. With a hemostat, the rubber tubing was adjusted to constrict the vessels in the porta hepatis. The liver was not manipulated during the experimental time period. One wedge biopsy and two needle biopsies (with a Tru-Cut needle) were taken at three time-points; Baseline (just before the application of PTC), post-ischemia (after 20 min of PTC) and post-reperfusion (after 20 min of reperfusion). The needle biopsies were immediately transferred to the required buffers as detailed below before being stored at 4 °C for further analyses. The wedge biopsies were immediately transferred to vials and flash-frozen in liquid nitrogen and stored at -70 °C until analysis. The liver resection was then carried out as planned.

Transmission electron microscopy
--------------------------------

The needle biopsies were fixed in 2% glutaraldehyde, 1% paraformaldehyde in 0.1 mol/L phosphate buffer, pH 7.4 for 10 min at room temperature and then stored at 4 °C. The samples were washed with 0.1 mol/L phosphate buffer, pH 7.4 and then postfixed for 2 h in 2% osmium tetroxide, 0.1 mol/L phosphate buffer, pH 7.4 at 4 °C. Dehydration was performed in ethanol, followed by acetone and the tissue samples were embedded in LX-112. Sections of approximately 70 nm were prepared by an ultramictrotome (Leica EM UC 6). Uranylacetate was added to the sections for contrast followed by lead citrate. A transmission electron microscope (Tecnai 12 Spirit Bio TWIN) was used at 100 kV for examination of the sections and a Veleta^®^ camera used for capturing digital images. Assessment of the electron microscopy (EM) findings included evaluation of the cellular architecture, hepatocyte morphology, sinusoids and bile canaliculi.

Morphometric image analysis
---------------------------

NIS Elements Basic Research software was used for quantification analysis of the sinusoids in the electron micrograph images. Pixel length measurements were applied on the sinusoidal endothelial lining surrounding vessels. The number of pixels was determined on one representative sinusoid for each patient and time point, and the length of the endothelial lining was correlated to the length of the entire sinusoid. The retrieved pixel value was related to actual μm for comparison between different images.

Immunoelectron microscopy
-------------------------

Needle biopsies were fixed in 3% paraformaldehyde in 0.1 mol/L phosphate buffer and rinsed in 0.1 mol/L phosphate buffer with subsequent addition of 2.3 mol/L sucrose and subsequently frozen in liquid nitrogen. An ultramicrotome (Leica EM UC 6) was used for the sectioning on carbon-reinforced formvar coated, 50 mesh Nickel grids. The grids were placed on drops of 0.1 mol/L phosphate buffer, 2% BSA, 2% Fish gelatin. Primary antibodies of TRX1 and GRX1 were applied on the sections (GRX1 1:5, TRX1 1:10, own production as described previously\[[@B20]\], in 0.1 mol/L of phosphate buffer, 0.1% BSA, 0.1% gelatin) overnight in a humidified chamber at room temperature. The sections were rinsed with the same buffer and detection of primary antibodies was achieved by protein A with 10 nm gold at a dilution of 1:100. A second wash of the sections was performed before fixation in 2% glutaraldehyde. Contrast was attained by 0.05% uranylacetate and sections were embedded in 1% methylcellulose. A transmission electron microscope (Tecnai G2 Bio TWIN) was used for examination and digital images captured by a Veleta camera^®^. Quantification of the staining was performed on 5 hepatocytes in close proximity to vessels for each tissue section. The number of gold particles in the cytosol and the nuclei were recorded.

RNA purification, cDNA synthesis and qPCR
-----------------------------------------

The fresh frozen wedge biopsies (approximately 10 mg) were homogenized and lysed using a TissueLyser LT with RLT plus lysis buffer (Qiagen). RNeasy Plus Mini Kit (Qiagen) was used for RNA purification according to the manufacturer's instructions, and RNA concentration determination was performed on a NanoDrop ND 100 Spectrophotometer (Saveen Werner). In order to validate the purity and quality of the RNA, Experion Automated Electrophoresis System with Experion RNA StdSens Analysis Kit (BIO-RAD) was used according to manufacturer's protocol. The mRNA quality was assessed for all samples and 6 out of 11 patients had good quality of samples from all time points.

For cDNA synthesis, 2 μg RNA was subjected to reverse transcription by Omniscript RT kit (Qiagen) according to manufacturer's instructions. Twenty-50 ng cDNA/reaction was used for qPCR in a BIO-RAD iCycler (BIO-RAD). Forward and reverse primers were designed *via* primer BLAST and Ape and purchased from Invitrogen (primer details in Supplementary Table [1](#T1){ref-type="table"}). The genes of interest were isoforms of thioredoxins (*TXN*) and glutaredoxins (*GLRX*) and also the gene of *xCT* and *NRF-2*, which are *SLC7A11* and *NFE2L2* respectively. The operation setting for qPCR instrument was the following: 50 °C for 2 min, 95 °C for 2 min with 40 amplification cycles of denaturation at 95 °C for 15 s. Annealing and elongation temperatures of 60 °C, 66 °C or 55 °C were used, depending on the gene of interest, during 30 s. The 2^-ΔΔCT^ method was used for quantification by normalizing the CT values against the housekeeping gene β-actin and retrieving fold change relative to the chosen control. A cut off value of 32 cycles was chosen and all primers were optimized for an efficiency of 90%-105%.

###### 

Patient demographics

  **Patient (gender/age)**   **Diagnosis**                   **Resection performed**                  **Preoperative chemotherapy**   **Peak AST,** μ**kat/L**   **Peak ALT,** μ**kat/L**   **Day of enzyme peak (AST, ALT), (d)**   **Peak bilirubin,** μ**mol/L, (d)**   **Fibrosis (stage)**   **Inflam-** **mation**   **Steatosis**
  -------------------------- ------------------------------- ---------------------------------------- ------------------------------- -------------------------- -------------------------- ---------------------------------------- ------------------------------------- ---------------------- ------------------------ ---------------
  P1 (M/75)                  mCRC                            Atypical resection                       Yes                             4.39                       2.23                       1                                        24 (1)                                1                      0                        1
  P2 (F/71)                  mCRC                            Multiple resections                      Yes                             23.05                      21.93                      2                                        53 (1)                                1                      0                        2
  P3 (M/39)                  Inflammatory pseudotumor        Extended right hepatectomy               No                              4.19                       4.81                       1                                        41 (1)                                \-                     \-                       1
  P4 (M/75)                  Malignant melanoma metastasis   Multiple atypical resections             Yes                             2.32                       1.90                       1                                        12 (2)                                1                      0                        1
  P5 (M/63)                  mCRC                            Bisegmentectomy                          Yes                             6.25                       7.03                       2                                        16 (1)                                1                      0                        1
  P6 (F/78)                  Carcinoid metastasis            Left hepatectomy                         No                              3.73                       2.89                       1                                        20 (1)                                1                      0                        1
  P7 (F/61)                  mCRC                            Right hepatectomy                        Yes                             7.14                       6.11                       1                                        14 (1)                                1                      0                        0
  P8 (M/55)                  Malignant melanoma metastasis   Right hepatectomy                        No                              7.90                       8.84                       2                                        48 (2)                                0                      0                        2
  P9 (M/68)                  mCRC                            Right hepatectomy + atypical resection   Yes                             3.85                       1.91                       1                                        82 (8)                                3-4                    2                        1
  P10 (M/37)                 mCRC                            Right hepatectomy                        Yes                             6.71                       3.96                       2                                        33 (2)                                1                      0                        0
  P11 (M/58)                 mCRC                            Right hepatectomy + atypical resection   Yes                             11.16                      9.28                       1                                        53 (2)                                1                      0                        3

Steatosis was defined as 1: Mild (\< 33%); 2: Moderate (33%-66%); 3: Severe (\> 66%). Fibrosis was defined as Stage 1: Portal fibrosis; Stage 2: Periportal fibrosis; Stage 3: Septal fibrosis; and Stage 4: Cirrhosis. mCRC: Metastatic colorectal cancer.

Statistical analysis
--------------------

The statistical analysis was performed using GraphPad Prism 6.0 software. The non-parametric Friedman test followed by Dunn's *post-hoc* test was used for the analysis of endothelial lining, gene expression data, and immunogold staining data. A *P* values of less than 0.05 was considered to be significant.

RESULTS
=======

Patients
--------

The median age of the patients was 68 (range 39-78) years. Light microscopy evaluation of tissue blocks collected for clinical routine diagnostics from macroscopically non-tumorous liver parenchyma revealed no major histological differences in the surgical specimens from the majority of patients. However, one patient had severe fibrosis, suspicious for cirrhosis (stage 3-4) combined with inflammation of grade 1-2 as defined by Batts and Ludwig\[[@B21]\]. Two patients had moderate steatosis (defined as 33%-66% of hepatocytes affected). Furthermore, one patient had pronounced steatosis (\> 67% of hepatocytes affected). The relevant patient data has been summarized in Table [1](#T1){ref-type="table"}.

Ultrastructural examination
---------------------------

At baseline the biopsies exhibited typical hepatic organization with normal hepatocyte and liver sinusoidal endothelial cell (LSEC) morphology. The hepatocytes had a normal appearance, intact plasma membranes, and large numbers of mitochondria without any discernible morphological aberrations at this point. The presence of lipofuscin lipid lysosomes was observed in most liver sections (Table [2](#T2){ref-type="table"}). The morphology of the Space of Disse showed hepatocytes with intact microvilli extensions and normal fenestrated LSECs lining the sinusoids (Figure [1A](#F1){ref-type="fig"} and D).

![Morphological changes in liver before and after ischemia and reperfusion, transmission electron micrographs of representative images of liver sections from one patient. A: Baseline, before induction of ischemia, shows the normal state of liver morphology at a cellular level; B: Morphology of a sinusoid with neighbouring hepatocytes 20 min after ischemia; C: Representative image of sinusoid and haptocytes 20 min after reperfusion; D: Endothelial lining of a sinusoid with hepatocyte microvilli; E: Morphology of the Space of Disse post-ischemia; F: Morphology of the space of disse post-reperfusion. SD: Space of disse; H: Hepatocyte; EC: Endothelial cells; VL: Vessel lumen; K: Kupffer cell. Arrow shows the absence of hepatocyte microvilli.](WJH-9-1261-g001){#F1}

###### 

Quantitative summary of ultrastructural changes studied by endothelial morphology, (*n*) patients out of total (11) patients

                                            **Baseline**   **Post-ischemia**   **Post-reperfusion**
  ----------------------------------------- -------------- ------------------- ----------------------
  Disruption of endothelium                 2/11           10/11               2/11
  Endothelial activation                    4/11           3/11                9/11
  Mitochondrial inclusions in hepatocytes   1/11           6/11                7/11
  Lipids, lipofucsin                        10/11          10/11               10/11

The most noticeable change post-ischemia was a disruption of the LSEC lining (Figure [1B](#F1){ref-type="fig"} and E) in 10 out of 11 patients (Table [2](#T2){ref-type="table"}). Apparent changes were seen in the space of Disse where the hepatocyte microvilli decreased in number and were in some cases undetectable (Figure [1E](#F1){ref-type="fig"}). There were no signs of hepatocyte plasma membrane rupture in either the ischemic or reperfused states. The hepatocytes exhibited some condensed nuclear chromatin but otherwise preserved hepatocyte morphology (Figure [1](#F1){ref-type="fig"}). In seven out of eleven patients, the hepatocyte mitochondria exhibited aggregates, so-called crystalline inclusions post-ischemia (Figure [2](#F2){ref-type="fig"} and Table [2](#T2){ref-type="table"}). These inclusions were accompanied by dilated mitochondria, both round and elongated types.

![Crystalline mitochondrial inclusions. A: Baseline, before induction of ischemia, shows hepatocyte mitochondria with normal appearance; B: Post-ischemia, showing mitochondria with the crystalline inclusions and a few dilated mitochondria; C: Mitochondrial inclusions, close-up of a single mega-mitochondrion showing the inclusions post-ischemia.](WJH-9-1261-g002){#F2}

There was a reactivation of the LSECs with pseudopod-like extensions appearing from the cells' surface (Figure [1F](#F1){ref-type="fig"} and Table [2](#T2){ref-type="table"}) post-reperfusion. The hepatocyte microvilli returned to their normal state within the space of Disse. LSEC apoptosis and phagocytosis by Kupffer cells was noticed in some sections. Hepatocyte morphology remained normal and the mitochondrial crystalline inclusions were persistent.

Morphometric analysis of endothelial cell lining loss
-----------------------------------------------------

In order to evaluate the apparent loss and re-growth of the LSEC lining, quantitative image analysis was performed. This was expressed as a percentage of intact LSEC lining of the total length of the hepatic sinusoid. There was a quantitatively significant reduction in the lining between baseline and post-ischemia (*P* = 0.0003) (Figure [3](#F3){ref-type="fig"}). However, there was no difference between the baseline level and the post-reperfusion level, indicating a recovery of the LSEC lining post-reperfusion.

![Morphometric analysis of endothelial lining. The percentage of attached endothelial lining along sinusoidal walls was quantified using network information services elements Basic Research Software. Statistical analysis was performed in Graphpad Prism, and differences were determined by the non-parametric Friedman test followed by Dunn's *post-hoc* test (*P* \< 0.01). Baseline: Before induction of ischemia; Ischemia: Twenty minutes of ischemia; Reperfusion: Twenty minutes after reperfusion.](WJH-9-1261-g003){#F3}

Gene expression analysis of redox regulating systems
----------------------------------------------------

To study the effects on expression of redox proteins during I/R, relative mRNA expression was investigated for genes implicated in the defense against oxidative stress. The gene expression of *NFE2L2* and *SLC7A11*, coding for the redox regulatory proteins NRF-2 and xCT, were investigated along with the TRX family of proteins. There were no differences post-ischemia or post-reperfusion compared with baseline (Table [3](#T3){ref-type="table"}) of the investigated genes.

###### 

Gene expression of redox proteins changes in mRNA expression compared to baseline, calculated using the 2^-ΔΔCT^ method

                **TNX1**      **TNX2**      **TNXR1**     **TNXR2**     **GLRX1**     **GLRX2**     **GLRX3**     **GLRX5**     **NFE2L2**    **SLC7A11**
  ------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- -------------
  Ischemia      1.09 ± 0.18   1.14 ± 0.30   1.02 ± 0.28   1.05 ± 0.23   1.19 ± 0.41   1.24 ± 0.46   1.03 ± 0.16   1.20 ± 0.27   0.83 ± 0.15   1.27 ± 1.24
  Reperfusion   1.12 ± 0.25   1.31 ± 0.57   0.97 ± 0.33   1.39 ± 0.79   1.12 ± 0.67   1.16 ± 0.43   1.16 ± 0.26   1.18 ± 0.63   1.00 ± 0.44   1.22 ± 0.78

Immunoelectron microscopy redox proteins
----------------------------------------

Immunogold staining for GRX1 and TRX1 was performed in order to study if a translocation of the proteins occurred during I/R. There were no significant changes in the amount of TRX1 either in the nuclei or the cytosol of the hepatocytes during I/R (Figure [4](#F4){ref-type="fig"}). However, the total amount of TRX differed in the hepatocytes between the time points, and during ischemia the level of TRX decreased in five patients, remained unaffected in three, and increased in two patients (Table [4](#T4){ref-type="table"}). The levels of GRX1 did not change in any of the patients during I/R (Figure [4](#F4){ref-type="fig"}).

###### 

Levels of TRX1, evaluated by immunogold staining, total number of gold particles present in five hepatocytes

  **Patient**   **Baseline**   **Post-ischemia**   **Post-reperfusion**
  ------------- -------------- ------------------- ----------------------
  P1            794            357                 414
  P2            310            202                 323
  P3            1217           235                 219
  P4            373            176                 298
  P5            324            231                 232
  P6            269            273                 443
  P7            575            569                 252
  P8            294            221                 699
  P9            535            863                 417
  P10           590            755                 272

![Quantification of immunogold staining. Number of gold particles of 5 hepatocytes for each time point and patient were recorded. A-C: Values from the TRX immunogold staining where A: Quantification of TRX in the cytosol; B: Quantification of TRX in the nuclei; C: Total value from of TRX both in cytosol and nuclei; D-F: Values from the quantification of GRX immunogold staining where D: Quantification of GRX in the cytosol; E: Quantification of GRX in the nuclei; F: Total value of GRX both in cytosol and nuclei. Baseline: Before induction of ischemia; Ischemia: Twenty minute of ischemia; Reperfusion: Twenty minute after reperfusion.](WJH-9-1261-g004){#F4}

DISCUSSION
==========

PTC is an effective method to reduce blood loss during liver resections but is used very selectively in routine clinical practice\[[@B22]\]. In general, the extent of I/R injury depends on the duration and magnitude of the ischemia. This study used PTC to investigate ultrastructural changes associated with warm I/R injury. PTC was carried out for a fixed amount of time in all patients and the liver was not manipulated during the experimental procedure and biopsy acquisition. Thus, controlled experimental conditions were established in order to obtain reliable and comparable data. Since PTC is carried out routinely with a 20 min application time, ethical considerations did not permit a more extensive study. The short ischemia time and defined time points of biopsy acquisition thus limited the experimental scope of this study. The findings, however, provide data from human, eventually facilitating our understanding of the complex pathological alterations associated with warm hepatic I/R injury.

Hepatocytes and the LSECs are the cell types most sensitive to I/R injury. In our study, the most noticeable finding in post-ischemia liver biopsies was the loss of the LSEC lining, which was seen in 10 of 11 patients. This finding was significant as shown by the morphometric analysis. According to the current knowledge, based mainly on animal studies, hepatocytes are more sensitive to warm ischemia and LSECs to cold ischemia\[[@B4],[@B23]\]. Detachment of these specific cells has been previously seen in cold ischemia models in rat\[[@B24],[@B25]\]. On the other hand one animal study reported that LSEC death may precede hepatocyte death in warm I/R injury\[[@B26]\]. Here we show, in the human setting, that the LSECs bore the major impact of warm ischemia, visualized by signs of endothelial cell disruption.

Another striking finding in this study was the formation of pseudopod-like projections from the LSEC surface which has been interpreted as a reactivation or reattachment of the LSECs as a response to reperfusion. This was found in 9 of 11 patients and became evident already after 20 min of reperfusion. This suggests that structural loss of LSEC may be reversible when the duration and magnitude of warm I/R injury is limited. It must be noted, however, that late response to reperfusion was not investigated in this study and secondary phases of injury to the LSECs are therefore unknown, if there are any. In a rat model of liver transplantation cold preservation of donor organs resulted in detachment of LSECs followed by some reattachment after reperfusion\[[@B27]\]. To our knowledge, this phenomenon has never been reported after warm ischemia.

We observed that the hepatocytes lost microvilli in the space of Disse after PTC and some had condensed nuclear chromatin. Furthermore, hepatic mitochondria were dilated and showed the presence of post-ischemic crystalline inclusions which prevailed after reperfusion. Consistent with previous reports, the inclusions almost exclusively appeared in dilated mitochondria\[[@B28]\]. Apart from these findings the overall morphology of hepatocytes was remarkably well preserved. This is in consistency with an earlier report that has shown that the hepatic ultrastructure was unaffected after intermittent PTC, indicating that the tissue might recover from the injury\[[@B29]\].

It is known that early hypoxic changes of the hepatocytes can be detected from the morphological alterations of mitochondria\[[@B30]\]. Mitochondrial crystalline inclusions are commonly seen in early alcohol and non-alcohol related liver diseases and aspirin toxicity\[[@B31]-[@B33]\]. These have been previously described as "para"-crystalline inclusions, however, an optical diffraction study showed that they are true crystals. To date, the composition of these inclusions remains unknown\[[@B34]\]. The mitochondria of *E. coli* exhibit crystalline inclusions visually similar to these and may arise from copolymerization of the protein Dps to the bacterial DNA as a protective response against oxidative and nutritional stress\[[@B35]\]. Mitochondrial inclusions could thus be an evolutionarily preserved event and adaptive response to the ischemic state rather than an occurrence secondary to the injury.

Previous studies on oxidative stress in I/R have demonstrated an activation of the transcription factor NRF-2, which regulates a number of redox proteins, including the TRX family of proteins\[[@B15],[@B36]\]. In our study PTC was used as a model of oxidative stress for studying redox proteins from the TRX family and their alterations in I/R injury. However, no changes on the mRNA levels of the redox proteins could be detected during the 20 min of PTC. Immunogold staining for TRX1 and GRX1 showed no changes in the hepatic GRX1 levels, but the levels of TRX1 present in the hepatocytes varied between the time points, suggesting a possible secretion of the protein. Although TRX1 lacks a translocation signal, this protein can be actively secreted through a leaderless secretory pathway that is independent of the classical endoplasmic reticulum-Golgi pathway\[[@B37]\]. These findings could support a tentative role for the TRX family of proteins in warm I/R injury, however further studies are needed to elucidate this.

We conclude that in a human experimental model of warm I/R injury the major effect observed at the ultrastructural level was on the non-parenchymal LSECs while hepatocytes morphology remained relatively intact apart from crystalline inclusions in the mitochondria after ischemia. Alterations that arise may be protective adaptations that to some extent seem to be reversible. In situ protein observations were compatible with a tentative role for the thioredoxin family of proteins in I/R injury.

COMMENTS
========

Background
----------

Portal triad clamping (PTC) is used during liver surgery to reduce blood loss. Limiting the blood supply in a tissue can cause ischemia reperfusion (I/R) injury to the tissue. The ischemic injury occurs initially with a switch from aerobic to anaerobic metabolism. Sudden oxygen burst upon returned vascular flow causes reperfusion injuries related to the production of reactive oxygen species (ROS).

Research frontiers
------------------

Primary endpoints of clinical studies concerning the PTC method has involved measurements of liver function test, duration of hospital stay, and post-operative complications. Hepatic tissue injury at the ultrastructural level has been sparsely studied and never has there been a differentiation between the ischemic and reperfusion state due to complexity arising in study design.

Innovations and breakthroughs
-----------------------------

This is the first study that investigates ultrastructural changes as a result of warm I/R injury during surgery at each point of tissue insult in the liver.

Applications
------------

Limiting the extent of tissue injury during surgery is important for the post-operative recovery of the patients. Evaluation of morphological changes as a result of PTC can provide insights for clinicians of their preferred methods. The results indicate that the changes on the ultrastructural level upon 20 min of ischemia are mainly localized in the sinusoids with a detachment of liver sinusoidal endothelial cells and a loss of hepatocyte microvilli in the Space of Disse. Upon reperfusion the sinusoids showed a reappearance of some liver sinusoidal endothelial cells. The hepatocytes displayed normal morphology with the exception of crystalline inclusions in mitochondria.

Terminology
-----------

Crystalline inclusions are characterized visually by dark lines in the mitochondria in the electron microscope. The true composition of the inclusions remain unknown, however *E.coli* have been recorded to display them as a means of protecting mitochondrial DNA in response to oxidative stress.

Peer-review
-----------

The authors present an interesting study on the microstructural alterations of liver in a warm ischemia-reperfusion setting.
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